anonymous
Guest
anonymous
Guest
Pfizer senior management are a bunch of Freddy cry babies. boo hooo, we can't invert. We don't hear other iconic American companies whining. Merck and BMS are happy to be in the US.
THANK YOU! We truly are a bunch of short-sighted dolts. Hey guys, where do you think we are going to get the $$$$$ we were planning on saving with the inversion?
You are right is not over. The inversion is to valuable. Consider this; GSk CEO Andrew witty out of London is now leaving officially retiring March 2017. He was a roadblock to a GSk takeover. Institutional investors want GSk broken up. Wouldn't be surprised if GSk becomes a target!